Titre:
  • Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Auteur:Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar; Van Laethem, Jean-Luc; Thaler, Josef; Bridgewater, John; Petersen, Lone Nørgård; Blons, Helene; Collette, Laurence; Van Cutsem, Eric; Rougier, Philippe; Salazar, Ramon; Bedenne, Laurent; Emile, Jean-François; Laurent-Puig, Pierre; Lepage, Come; PETACC-8 Study Investigators,
Informations sur la publication:Lancet oncology, 15, 8, page (862-873)
Statut de publication:Publié, 2014-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adenocarcinoma -- drug therapy -- genetics -- pathology -- surgery
Adult
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Chemotherapy, Adjuvant
Colonic Neoplasms -- drug therapy -- genetics -- pathology -- surgery
Diarrhea -- chemically induced
Disease-Free Survival
Drug Eruptions -- etiology
Exons -- genetics
Female
Fluorouracil -- adverse effects -- therapeutic use
Humans
Infusions, Intravenous -- adverse effects
Intention to Treat Analysis
Leucovorin -- adverse effects -- therapeutic use
Male
Middle Aged
Mucositis -- chemically induced
Neoplasm Staging
Organoplatinum Compounds -- adverse effects -- therapeutic use
Proto-Oncogene Proteins -- genetics
ras Proteins -- genetics
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(14)70227-X
info:pii/S1470-2045(14)70227-X
info:scp/84903547973
info:pmid/24928083